Published in Kidney Int on May 16, 2007
Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J Am Soc Nephrol (2009) 5.01
Hyaluronan as an immune regulator in human diseases. Physiol Rev (2011) 2.74
Hyaluronan-CD44 interactions as potential targets for cancer therapy. FEBS J (2011) 1.63
Peptide nanofibers preconditioned with stem cell secretome are renoprotective. J Am Soc Nephrol (2011) 1.57
Pathophysiology of acute kidney injury. Compr Physiol (2012) 1.56
Mesenchymal stem cell-based therapy: a new paradigm in regenerative medicine. J Cell Mol Med (2009) 1.49
Mesenchymal stem cell secreted vesicles provide novel opportunities in (stem) cell-free therapy. Front Physiol (2012) 1.45
Adipose tissue-derived mesenchymal stem cells improve revascularization outcomes to restore renal function in swine atherosclerotic renal artery stenosis. Stem Cells (2012) 1.44
The life and fate of mesenchymal stem cells. Front Immunol (2014) 1.27
Primary mesenchymal stem and progenitor cells from bone marrow lack expression of CD44 protein. J Biol Chem (2012) 1.23
Influence of adult mesenchymal stem cells on in vitro vascular formation. Tissue Eng Part A (2009) 1.22
Stem cells derived from human amniotic fluid contribute to acute kidney injury recovery. Am J Pathol (2010) 1.22
Kallikrein-modified mesenchymal stem cell implantation provides enhanced protection against acute ischemic kidney injury by inhibiting apoptosis and inflammation. Hum Gene Ther (2008) 1.20
Macrophage stimulating protein may promote tubular regeneration after acute injury. J Am Soc Nephrol (2008) 1.19
Enhancing the migration ability of mesenchymal stromal cells by targeting the SDF-1/CXCR4 axis. Biomed Res Int (2013) 1.19
Synergistic effects of SDF-1α chemokine and hyaluronic acid release from degradable hydrogels on directing bone marrow derived cell homing to the myocardium. Biomaterials (2012) 1.18
The role of microvesicles in tissue repair. Organogenesis (2011) 1.15
Therapeutic potential of mesenchymal stem cells in regenerative medicine. Stem Cells Int (2013) 1.14
Bone-marrow-derived mesenchymal stem cells for organ repair. Stem Cells Int (2013) 1.14
Enforced hematopoietic cell E- and L-selectin ligand (HCELL) expression primes transendothelial migration of human mesenchymal stem cells. Proc Natl Acad Sci U S A (2011) 1.14
Human amniotic fluid stem cell preconditioning improves their regenerative potential. Stem Cells Dev (2011) 1.12
Macrophage-associated mesenchymal stem cells assume an activated, migratory, pro-inflammatory phenotype with increased IL-6 and CXCL10 secretion. PLoS One (2012) 1.10
Transplantation of bone marrow-derived MSCs improves cisplatinum-induced renal injury through paracrine mechanisms. Exp Mol Pathol (2013) 1.04
Mesenchymal stem cells ameliorate rhabdomyolysis-induced acute kidney injury via the activation of M2 macrophages. Stem Cell Res Ther (2014) 1.03
Arterially delivered mesenchymal stem cells prevent obstruction-induced renal fibrosis. J Surg Res (2010) 1.02
Bone marrow-derived mesenchymal stem cells protect against cisplatin-induced acute kidney injury in rats by inhibiting cell apoptosis. Int J Mol Med (2013) 1.00
Role of mesenchymal stem cell-derived microvesicles in tissue repair. Pediatr Nephrol (2013) 1.00
Molecular mechanisms involved in mesenchymal stem cell migration to the site of acute myocardial infarction. Int J Cell Biol (2009) 0.99
Injection of amniotic fluid stem cells delays progression of renal fibrosis. J Am Soc Nephrol (2012) 0.98
Homing of Mesenchymal Stem Cells. Transfus Med Hemother (2008) 0.97
Biodistribution of mesenchymal stem cell-derived extracellular vesicles in a model of acute kidney injury monitored by optical imaging. Int J Mol Med (2014) 0.97
Possible mechanisms of kidney repair. Fibrogenesis Tissue Repair (2009) 0.95
Cell-based therapy for acute organ injury: preclinical evidence and ongoing clinical trials using mesenchymal stem cells. Anesthesiology (2014) 0.94
Mesenchymal stem/stromal cells as a delivery platform in cell and gene therapies. BMC Med (2015) 0.91
Mesenchymal stem cell treatment for chronic renal failure. Stem Cell Res Ther (2014) 0.91
Differential effects of kidney-lung cross-talk during acute kidney injury and bacterial pneumonia. Kidney Int (2011) 0.91
Extracellular membrane vesicles from umbilical cord blood-derived MSC protect against ischemic acute kidney injury, a feature that is lost after inflammatory conditioning. J Extracell Vesicles (2013) 0.90
Human liver stem cells and derived extracellular vesicles improve recovery in a murine model of acute kidney injury. Stem Cell Res Ther (2014) 0.89
Interactions between CD44 and Hyaluronan in Leukocyte Trafficking. Front Immunol (2015) 0.88
Renal stem cell reprogramming: Prospects in regenerative medicine. World J Stem Cells (2014) 0.87
Potential advantages of acute kidney injury management by mesenchymal stem cells. World J Stem Cells (2014) 0.87
Mesenchymal stromal cells in renal ischemia/reperfusion injury. Front Immunol (2012) 0.87
Protective effect and localization by optical imaging of human renal CD133+ progenitor cells in an acute kidney injury model. Physiol Rep (2014) 0.86
Effects of mesenchymal stromal cell-derived extracellular vesicles on tumor growth. Front Immunol (2014) 0.86
CD44 and hyaluronan help mesenchymal stem cells move to a neighborhood in need of regeneration. Kidney Int (2007) 0.86
A novel in vivo model for evaluating functional restoration of a tissue-engineered salivary gland. Laryngoscope (2013) 0.85
Combination stem cell therapy for heart failure. Int Arch Med (2010) 0.85
Expression of nestin, vimentin, and NCAM by renal interstitial cells after ischemic tubular injury. J Biomed Biotechnol (2010) 0.85
Regenerative medicine for the kidney: renotropic factors, renal stem/progenitor cells, and stem cell therapy. Biomed Res Int (2014) 0.84
Mesenchymal Stem Cell-Based Therapy for Kidney Disease: A Review of Clinical Evidence. Stem Cells Int (2016) 0.83
The role of microvesicles derived from mesenchymal stem cells in tissue regeneration; a dream for tendon repair? Muscles Ligaments Tendons J (2012) 0.82
Erythropoietin gene-enhanced marrow mesenchymal stromal cells decrease cisplatin-induced kidney injury and improve survival of allogeneic mice. Mol Ther (2011) 0.82
Concise review: mesenchymal stem cell treatment for ischemic kidney disease. Stem Cells (2013) 0.82
Extracellular Vesicles in Renal Pathophysiology. Front Mol Biosci (2017) 0.82
Hyaluronan as a therapeutic target in human diseases. Adv Drug Deliv Rev (2015) 0.81
Emerging therapeutic targets of sepsis-associated acute kidney injury. Semin Nephrol (2015) 0.81
Adipose tissue-derived mesenchymal stem cells: a fat chance of curing kidney disease? Kidney Int (2012) 0.81
Mesenchymal Stromal Cells Affect Disease Outcomes via Macrophage Polarization. Stem Cells Int (2015) 0.80
Modulating the Adhesion of Haematopoietic Stem Cells with Chemokines to Enhance Their Recruitment to the Ischaemically Injured Murine Kidney. PLoS One (2013) 0.79
Renal repair: role of bone marrow stem cells. Pediatr Nephrol (2008) 0.79
Immature Dental Pulp Stem Cells Showed Renotropic and Pericyte-Like Properties in Acute Renal Failure in Rats. Cell Med (2014) 0.78
Uncovering the dual role of RHAMM as an HA receptor and a regulator of CD44 expression in RHAMM-expressing mesenchymal progenitor cells. Front Cell Dev Biol (2015) 0.77
Mesenchymal stem cells as a therapeutic approach to glomerular diseases: benefits and risks. Kidney Int Suppl (2011) (2011) 0.77
Bone-derived mesenchymal stromal cells from HIV transgenic mice exhibit altered proliferation, differentiation capacity and paracrine functions along with impaired therapeutic potential in kidney injury. Exp Cell Res (2013) 0.76
WNT/β-Catenin Signaling Is Required for Integration of CD24+ Renal Progenitor Cells into Glycerol-Damaged Adult Renal Tubules. Stem Cells Int (2015) 0.76
Intra-arterial catheter system to repeatedly deliver mesenchymal stem cells in a rat renal failure model. Clin Exp Nephrol (2015) 0.76
Targeting Endogenous Repair Pathways after AKI. J Am Soc Nephrol (2015) 0.76
"Opening" the mesenchymal stem cell tool box. Eur J Dent (2009) 0.75
Preserved Nephrogenesis Following Partial Nephrectomy in Early Neonates. Sci Rep (2016) 0.75
MESENCHYMAL STEM CELLS PROTECT AGAINST OBSTRUCTION-INDUCED RENAL FIBROSIS BY DECREASING STAT3 ACTIVATION AND STAT3-DEPENDENT MMP-9 PRODUCTION. Am J Physiol Renal Physiol (2016) 0.75
The effects of glomerular and tubular renal progenitors and derived extracellular vesicles on recovery from acute kidney injury. Stem Cell Res Ther (2017) 0.75
Therapeutic Potential of Bone Marrow-Derived Mesenchymal Stem Cells on Experimental Liver Injury Induced by Schistosoma mansoni: A Histological Study. Int J Stem Cells (2016) 0.75
Back from the brink: a mesenchymal stem cell infusion rescues kidney function in acute experimental rhabdomyolysis. Stem Cell Res Ther (2014) 0.75
Nestin Positive Bone Marrow Derived Cells Responded to Injury Mobilize into Peripheral Circulation and Participate in Skin Defect Healing. PLoS One (2015) 0.75
Study of the Effect of Route of Administration of Mesenchymal Stem Cells on Cisplatin-Induced Acute Kidney Injury in Sprague Dawley Rats. Int J Stem Cells (2016) 0.75
Mesenchymal Stem Cell-Derived Extracellular Vesicles: Roles in Tumor Growth, Progression, and Drug Resistance. Stem Cells Int (2017) 0.75
Cardiomyogenic Differentiation of Human Dental Follicle-derived Stem Cells by Suberoylanilide Hydroxamic Acid and Their In Vivo Homing Property. Int J Med Sci (2016) 0.75
Hyaluronic acid coatings as a simple and efficient approach to improve MSC homing toward the site of inflammation. Sci Rep (2017) 0.75
The exciting "bench to bedside" journey of cell therapies for acute kidney injury and renal transplantation. J Nephrol (2017) 0.75
Expression of CD44 standard form and variant isoforms in human bone marrow stromal cells. Saudi Pharm J (2017) 0.75
CD44 is the principal cell surface receptor for hyaluronate. Cell (1990) 11.01
Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev (2000) 8.24
Features of apoptotic cells measured by flow cytometry. Cytometry (1992) 6.45
A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. Proc Natl Acad Sci U S A (1992) 4.77
Nine scoring models for short-term mortality in alcoholic hepatitis: cross-validation in a biopsy-proven cohort. Aliment Pharmacol Ther (2014) 3.98
Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. Genes Dev (1999) 3.32
Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells. Gastroenterology (1997) 3.00
Efficacy and safety of infliximab and adalimumab in Crohn's disease: a single centre study. Aliment Pharmacol Ther (2012) 2.89
The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis. Dig Liver Dis (2006) 2.83
The release of platelet-activating factor from human endothelial cells in culture. J Immunol (1983) 2.41
Bioactive IL-18 expression is up-regulated in Crohn's disease. J Immunol (1999) 2.38
CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor. J Cell Biol (1995) 2.38
Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development. J Exp Med (1994) 2.37
CD44H regulates tumor cell migration on hyaluronate-coated substrate. J Cell Biol (1992) 2.28
Granulocyte- and granulocyte-macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferate. Nature (1989) 2.25
Early recognition of potentially fatal necrotizing fasciitis. The use of frozen-section biopsy. N Engl J Med (1984) 2.24
Distinct effects of two CD44 isoforms on tumor growth in vivo. J Exp Med (1991) 2.23
Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM. Proc Natl Acad Sci U S A (1993) 2.17
Matrix metalloproteinase-7-mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity. Cancer Res (2001) 2.12
Leu-8/TQ1 is the human equivalent of the Mel-14 lymph node homing receptor. Nature (1989) 2.12
Induction of apoptosis of metastatic mammary carcinoma cells in vivo by disruption of tumor cell surface CD44 function. J Exp Med (1997) 2.11
Sarcomas: genetics, signalling, and cellular origins. Part 1: The fellowship of TET. J Pathol (2007) 2.03
The primary structure of the human leukocyte antigen CD37, a species homologue of the rat MRC OX-44 antigen. J Exp Med (1989) 1.99
Varicella immunization practices and the factors that influence them. Arch Pediatr Adolesc Med (1999) 1.83
Identification of hyaluronic acid binding sites in the extracellular domain of CD44. J Cell Biol (1993) 1.77
Organ distribution in rats of two members of the low-density lipoprotein receptor gene family, gp330 and LRP/alpha 2MR, and the receptor-associated protein (RAP). J Histochem Cytochem (1994) 1.72
The angiogenesis induced by HIV-1 tat protein is mediated by the Flk-1/KDR receptor on vascular endothelial cells. Nat Med (1996) 1.72
Role of platelet-activating factor in cardiovascular pathophysiology. Physiol Rev (2000) 1.70
Constitutive expression of p53 protein in enriched normal human marrow blast cell populations. Blood (1992) 1.69
Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities. Hepatology (1995) 1.69
Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines. J Crohns Colitis (2013) 1.67
Behçet's disease: an immune-mediated vasculitis involving vessels of all sizes. Int J Clin Lab Res (1997) 1.66
Release of platelet-activating factor (PAF) and histamine. II. The cellular origin of human PAF: monocytes, polymorphonuclear neutrophils and basophils. Immunology (1981) 1.62
Infliximab in the treatment of Crohn's disease: predictors of response in an Italian multicentric open study. Dig Liver Dis (2005) 1.61
Isolation of cDNAs for two distinct human Fc receptors by ligand affinity cloning. EMBO J (1988) 1.60
Human liver stem cell-derived microvesicles accelerate hepatic regeneration in hepatectomized rats. J Cell Mol Med (2009) 1.58
Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement. Dig Liver Dis (2005) 1.57
Nephrin redistribution on podocytes is a potential mechanism for proteinuria in patients with primary acquired nephrotic syndrome. Am J Pathol (2001) 1.57
Cell cycle-specific effects of lovastatin. Proc Natl Acad Sci U S A (1991) 1.54
Antibody-induced redistribution of Heymann antigen on the surface of cultured glomerular visceral epithelial cells: possible role in the pathogenesis of Heymann glomerulonephritis. J Immunol (1985) 1.52
Synthesis and release of platelet-activating factor by human vascular endothelial cells treated with tumor necrosis factor or interleukin 1 alpha. J Biol Chem (1988) 1.52
Tumour necrosis factor in serum and synovial fluid of patients with active and severe rheumatoid arthritis. Ann Rheum Dis (1990) 1.50
Natural ligands of the B cell adhesion molecule CD22 beta carry N-linked oligosaccharides with alpha-2,6-linked sialic acids that are required for recognition. J Biol Chem (1993) 1.49
HIV-1 kills renal tubular epithelial cells in vitro by triggering an apoptotic pathway involving caspase activation and Fas upregulation. J Clin Invest (1998) 1.49
Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood. Blood (1997) 1.48
CD22, a B cell-specific immunoglobulin superfamily member, is a sialic acid-binding lectin. J Biol Chem (1993) 1.46
Human endothelial cells are target for platelet-activating factor. I. Platelet-activating factor induces changes in cytoskeleton structures. J Immunol (1987) 1.46
Glycosylation provides both stimulatory and inhibitory effects on cell surface and soluble CD44 binding to hyaluronan. J Cell Biol (1998) 1.43
Regulation of CD44 binding to hyaluronan by glycosylation of variably spliced exons. J Cell Biol (1995) 1.43
Late administration of monoclonal antibody to leukocyte function-antigen 1 abrogates incipient murine cerebral malaria. Eur J Immunol (1991) 1.42
[Analysis of urinary sediments in a nephrological laboratory: a precious art but too expensive?]. G Ital Nefrol (2002) 1.39
Erythrocyte antioxidant activity, serum ceruloplasmin, and trace element levels in subjects with alcoholic liver disease. Am J Clin Pathol (1992) 1.38
Mucosal and systemic antibody levels against Helicobacter pylori do not parallel gastric inflammatory changes. Ital J Gastroenterol Hepatol (1998) 1.37
Expressed cadherin pseudogenes are localized to the critical region of the spinal muscular atrophy gene. Proc Natl Acad Sci U S A (1995) 1.37
Inhibition of tumor growth in vivo with a soluble CD44-immunoglobulin fusion protein. J Exp Med (1992) 1.36
Inhibition of tumor growth in vivo by hyaluronan oligomers. Int J Cancer (1998) 1.35
Induction of placental heme oxygenase-1 is protective against TNFalpha-induced cytotoxicity and promotes vessel relaxation. Mol Med (2000) 1.32
Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan. J Cell Biol (1996) 1.31
CD44 as a receptor for colonization of the pharynx by group A Streptococcus. J Clin Invest (2000) 1.30
Molecular epidemiology of hepatitis C virus infection among intravenous drug users. J Hepatol (1995) 1.29
HLA-DR antigens on colonic epithelial cells in inflammatory bowel disease: I. Relation to the state of activation of lamina propria lymphocytes and to the epithelial expression of other surface markers. Clin Exp Immunol (1987) 1.28
Redirection of tumor metastasis by expression of E-selectin in vivo. J Exp Med (1996) 1.27
Mediators of immune-complex-induced aggregation of polymorphonuclear neutrophils. II. Platelet-activating factor as the effector substance of immune-induced aggregation. Int Arch Allergy Appl Immunol (1981) 1.27
A novel diagnostic tool for detecting functional patency of the small bowel: the Given patency capsule. Endoscopy (2005) 1.26
Immunoregulation in the gut: success and failures in human disease. Gut (2002) 1.25
Release of platelet-activating factor and histamine. I. Effect of immune complexes, complement and neutrophils on human and rabbit mastocytes and basophils. Immunology (1977) 1.25
Maternal vascular prostacyclin activity in pre-eclampsia. Lancet (1980) 1.24
Hyperacute renal allograft rejection in the rabbit. The role of platelet-activating factor and of cationic proteins derived from polymorphonuclear leukocytes and from platelets. Lab Invest (1984) 1.24
Cytokine-induced beta-galactoside alpha-2,6-sialyltransferase in human endothelial cells mediates alpha 2,6-sialylation of adhesion molecules and CD22 ligands. J Biol Chem (1994) 1.24
Fas and tumor necrosis factor receptor-mediated cell death: similarities and distinctions. J Exp Med (1994) 1.23
delta 9-tetrahydrocannabinol in clinical oncology. JAMA (1981) 1.23
The CD95 (APO-1/Fas) receptor activates NF-kappaB independently of its cytotoxic function. J Biol Chem (1996) 1.20
The CD85/LIR-1/ILT2 inhibitory receptor is expressed by all human T lymphocytes and down-regulates their functions. J Immunol (2000) 1.20
Formation of immune deposits and disease. Lab Invest (1986) 1.20
Angiopoietin-1 and angiopoietin-2 activate trophoblast Tie-2 to promote growth and migration during placental development. Am J Pathol (2000) 1.19
Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-up. Aliment Pharmacol Ther (2007) 1.18
Role of soluble mediators in angiogenesis. Eur J Cancer (1996) 1.17
Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: a prospective study. Gastroenterology (1995) 1.17
Tumor necrosis factor alpha-induced angiogenesis depends on in situ platelet-activating factor biosynthesis. J Exp Med (1994) 1.17
Effects of 1,25(OH)2D3 in experimental mesangial proliferative nephritis in rats. Kidney Int (2001) 1.17
Insulin-like growth factor binding protein-3 induces angiogenesis through IGF-I- and SphK1-dependent mechanisms. J Thromb Haemost (2007) 1.16
Angiopoietin-2 is implicated in the regulation of tumor angiogenesis. Am J Pathol (2001) 1.16
Spontaneous cytotoxicity of intestinal intraepithelial lymphocytes: clues to the mechanism. Clin Exp Immunol (1993) 1.16
Alkyl-ether phosphoglycerides influence calcium fluxes into human endothelial cells. J Immunol (1985) 1.16
Identification of the intracytoplasmic region essential for signal transduction through a B cell activation molecule, CD40. Eur J Immunol (1990) 1.16
DNA strand breaks occurring during apoptosis - their early insitu detection by the terminal deoxynucleotidyl transferase and nick translation assays and prevention by serine protease inhibitors. Int J Oncol (1992) 1.15
Cyclosporin A inhibits CD40 ligand expression in T lymphocytes. J Clin Invest (1994) 1.15
Control of spine formation by electrical activity in the adult rat cerebellum. Proc Natl Acad Sci U S A (1999) 1.15